Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Shandong Weigao Orthopaedic Device Co EBITDA Margin %?
Shandong Weigao Orthopaedic Device CoSHSE:688161 -4.25%75 EBITDA Margin % is 17.80% as of Mar. 2026, which is 50% below its 10-year median of 35.78. GuruFocus rates SHSE:688161 with a GF Score™ of 75/100 and a GF Value™ of ¥32.42 (Significantly Undervalued). The stock has 4 warning signs investors should review. Among 816 Medical Devices & Instruments companies, Shandong Weigao Orthopaedic Device Co ranks better than 75.74% on this metric.
Shandong Weigao Orthopaedic Device Co (SHSE:688161) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Shandong Weigao Orthopaedic Device Co EBITDA Margin % Related Terms
Shandong Weigao Orthopaedic Device Co EBITDA Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shandong Weigao Orthopaedic Device Co EBITDA Margin % Chart
SHSE:688161 vs ABT, SYK, MDT: EBITDA Margin % Comparison
For the Medical Devices subindustry, Shandong Weigao Orthopaedic Device Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shandong Weigao Orthopaedic Device Co EBITDA Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Shandong Weigao Orthopaedic Device Co's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Shandong Weigao Orthopaedic Device Co's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shandong Weigao Orthopaedic Device Co (SHSE:688161) has a EBITDA Margin % of 17.80% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Shandong Weigao Orthopaedic Device Co and its competitors. This is 50% below median its historical median of 35.78. Over the past decade, Shandong Weigao Orthopaedic Device Co's EBITDA Margin % has ranged from 15.19 to 100.43. According to the industry distribution chart, Shandong Weigao Orthopaedic Device Co ranks #198 out of 816 companies in the Medical Devices & Instruments industry, placing it in the top 24.3%.
Is Shandong Weigao Orthopaedic Device Co's EBITDA Margin % too high?
Shandong Weigao Orthopaedic Device Co's current EBITDA Margin % of 17.80% is 50% below median its 10-year median of 35.78. Over the past 10 years, this metric has ranged from a low of 15.19 to a high of 100.43. The Medical Devices & Instruments industry median EBITDA Margin % is 7.46. Shandong Weigao Orthopaedic Device Co's value of 17.80% is 138.8% above this industry median. Based on the distribution chart, Shandong Weigao Orthopaedic Device Co ranks #198 out of 816 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Shandong Weigao Orthopaedic Device Co has a GF Score™ of 75/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shandong Weigao Orthopaedic Device Co's EBITDA Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Shandong Weigao Orthopaedic Device Co ranks #198 out of 816 companies for EBITDA Margin %. This places Shandong Weigao Orthopaedic Device Co in the top 24% of its industry — outperforming the majority of peers. The industry median EBITDA Margin % is 7.46. Shandong Weigao Orthopaedic Device Co's value of 17.80% is 138.8% above this benchmark. Historically, Shandong Weigao Orthopaedic Device Co's own EBITDA Margin % has ranged from 15.19 to 100.43 over the past decade. While the company's 10-year median is 35.78 vs. the industry median of 7.46, Shandong Weigao Orthopaedic Device Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Medical Devices & Instruments company?
The median EBITDA Margin % among Medical Devices & Instruments companies is 7.46, based on 816 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shandong Weigao Orthopaedic Device Co's current EBITDA Margin % of 17.80% is 138.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Shandong Weigao Orthopaedic Device Co and its competitors. For the Medical Devices & Instruments industry, the median EBITDA Margin % is 7.46 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shandong Weigao Orthopaedic Device Co's current EBITDA Margin % is 17.80%, which is 50% below median its own 10-year median of 35.78. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shandong Weigao Orthopaedic Device Co stock overvalued right now?
Based on GuruFocus' analysis, Shandong Weigao Orthopaedic Device Co (SHSE:688161) is currently considered Significantly Undervalued. The stock's GF Value™ is ¥32.42, compared to a current price of ¥21.87 — trading 32.5% below its estimated fair value. The current EBITDA Margin % is 17.80%, which is 50% below median its 10-year median of 35.78 and 138.8% above the Medical Devices & Instruments industry median of 7.46. Shandong Weigao Orthopaedic Device Co's overall GF Score™ is 75/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Shandong Weigao Orthopaedic Device Co (SHSE:688161), the current EBITDA Margin % is 17.80% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shandong Weigao Orthopaedic Device Co (SHSE:688161) Overvalued in 2026?
Based on GuruFocus' analysis, Shandong Weigao Orthopaedic Device Co stock appears to be undervalued.
The current stock price of ¥21.87 is trading 32.5% below its estimated GF Value™ of ¥32.42.
GuruFocus considers Shandong Weigao Orthopaedic Device Co to be Significantly Undervalued.
Key valuation signals for SHSE:688161:
EBITDA Margin %: 17.80% (50% below median its 10-year median of 35.78)
GF Value™: ¥32.42 vs. price of ¥21.87 (32.5% below fair value)
Industry Position: 138.8% above the Medical Devices & Instruments median (#198 of 816)
No single metric tells the full story. See the SHSE:688161 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shandong Weigao Orthopaedic Device Co Business Description
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688161 has been successfully added to your 
